...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Teflon Don

100% bang on drago!

The presentation was very exciting in terms of the science and the connections that Dr Lakhotia and team have built. Other than saying they were very busy Don did not even have the decency to give them credit for these remarkable achievements. This man is not a leader in any sense of the word.

But when it came to the business and value creation, teflon Don showed us pages 15 and 16...Don's excuses for not doing his job.

Don was an excellent parrot presenting, and by juxtaposition, taking credit for the incredible science and trials that the ZE team has built but as soon as it came to value creation (failure) Don blamed it on poor equity markets. He used Covid as his excuse for 3 years of achieving nothing at RVX and now, with an extremely promising zen3694, he blames the lack of value on something out of his control.

If Don had any leadersip ability at all he would be finding a competent biotech CEO to complement Dr Lakhotia and his team. This is not going to happen at ZCC because Don needs to steal the limelight.

It is very sad to see such assents squandered by incompetence. JMO

Toinv

Share
New Message
Please login to post a reply